scholarly journals PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study

BioDrugs ◽  
2019 ◽  
Vol 33 (5) ◽  
pp. 555-570 ◽  
Author(s):  
Niels Reinmuth ◽  
Maciej Bryl ◽  
Igor Bondarenko ◽  
Kostas Syrigos ◽  
Vladimir Vladimirov ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document